top of page
Doctor with Files

INTRODUCING AADDHYA'S WELLNESS PRIVATE LIMITED

Dr. Avinash Pandey DM ( Medical Oncology) Tata Memorial Hospital, Mumbai

Dr. Avinash Pandey did his  DM Medical Oncology from Prestigious Tata Memorial Hospital Mumbai. He was Ex Assistant Professor at AIIMS New Delhi and Tata memorial hospital, Mumbai. He was Ex Assistant Professor and Head, Dept of Medical Oncology at IGIMS Patna, where he has treated thousands of cancer patients. He has more than 70 national/ International publications to his credit. He has presented several research papers at Chicago, Barcelona, Dubai and London. He is active member of American Society of Clinical Oncology ASCO, European Society of Medical Oncology ESMO and American Society of Hematology ASH. He is a well known national faculty in several Oncology conferences and member of ICON and ISMPO. He treat solid tumors, blood cancers and childhood malignancies

Learn More
Home: Welcome
Home: Bookings Widget

REVIEWS AND TESTIMONIALS

prize.jpg
Pediatric cancer.jpg
Best pediatric.jpg
jagannath mishra.jpg

Listens with patience and does the appropriate treatment required. Thanks for his friendly behavior and cooperative attitude.

Nirja Kumari ( Practo)

Fantastic experience with this doctor. Doctor is very polite and listen to the patient completely. Gives complete time to patients to explain the concern.Available on mobile for help. I would recommend he is one of the best doctor have visited in Medical Oncology

Himanshu Kumar

today i alive due to the treatment of avinash sir .he given 8 time chemotherapy and 8 time oral chemo, i taken all given doz and today i spending my normal life.

Aaditya Singh

Excellent, the consultation from Doctor is comprehensive. The doctor gave multiple scenario diagnosis recommendations. I appreciate the professional level put forward.

Jagannath Mishra (Ex Cheif Minister- Bihar)

Home: Testimonials
zee news.jpg

OPENING HOURS

Come Visit

Mon - Sat: 6:00 PM - 9:00 PM

Sun: Closed

Book Prior Appointments by calling on

08969981217,07634931217

Home: Opening Hours

PUBLISHED WORK

My Written Works

self best.jpg

MY RESEARCH PUBLICATIONS

1.Wadasadawala T, Pandey A, Agarwal JP, Jalali R, Laskar SG, Chowdhary S, et al. Radiation therapy with implanted cardiac pacemaker devices : A clinical and
dosimetric analysis of patients and proposed precautions. Clin Oncol (R Coll Radiol) 2011;23:79-85.
2. Pandey A, Noronha V, Joshi A, Tongaonkar H, Bakshi G, Prabhash K.Resistant metastatic penile carcinoma and response to biochemotherapy with paclitaxel
and epidermal growth factor receptor monoclonal antibody,Nimotuzumab. Indian J Med Paediatr Oncol. 2013 Jan;34(1):24-7.
3. Prabhash K, Pandey A, Kar R, Munshi A, Naronah V, Agarwal JP.Bilateral visual blurring as first symptom of extracranial lung metastasis. Indian J Med Paediatr
Oncol. 2012 Jan;33(1):48-50.
4. Agarwal JP, Gupta T, Pandey A..Human Papillomavirus and Oropharyngeal Cancer:shifting paradigms and exploring options. Natl Med J India. 2011 MarApr;24(2):88-90
5. Pandey A, Bhosale B, Pandita V, Singh S, Ghosh J , Bajpai J . Carboplatin Hypersensitivity in relapsed ovarian carcinoma: A Therapeutic challenge.
Indian J Med Paediatr Oncol. 2014 Jan;35(1):17-20.
6. Pandey A, Mittal S, Thippeswamy R,Rajamanickam D, Gokarn A,Khattry N.Incidence of engraftment fever post autologous transplant for lymphomas and
analysis of risk factors.Meeting Library » Abstracts » 2013 ASCO Annual Meeting.Available at https://meetinglibrary.asco.org › ... › Abstracts › 2013 ASCO
Annual Meeting- Poster presentation at ASCO 2013 Chicago ,USA
7. Pandey AV, Phillip DS, Noronha V, Joshi A, Janu A, Jambekar N, Kaushal R, Mahajan A, Prabhash K. Maintenance pemetrexed in nonsmall cell lung
carcinoma: Outcome analysis from a tertiary care center. Indian J Med Paediatr Oncol 2015;36:238-42
8. Pandey A, Desai A, Ostwal V, Patil V, Kulkarni A, Kulkarni R, Patil N, Chaukar D, Prabhash K, Banavali SD. Outcome of operable oral cavity cancer and impact
of maintenance metronomic chemotherapy: A retrospective study from rural India. South Asian J Cancer 2016;5:52-5
9. Pandey A, Abhay D, Sunny J, Vikas O, Vijay P, Rajeshri K, Netaji P, Sudeep G, Banavali SD. Outcomes of advanced epithelial ovarian cancer with integration
of metronomic chemotherapy: An Indian rural cancer centre experience. South Asian J Cancer 2016;5:59-62
10. Sirohi B, Dawood S, Rastogi S, Pandey A, Bal M, Shetty N, Shrikhande S V. Treatment of patients with metastatic pancreatic cancer: Experience from a tertiary
Indian cancer center. Indian J Cancer 2015;52:449-52
11. Pandey AV, Phillip DS, Noronha V, Joshi A, Janu A, Jambekar N, Kaushal R, Mahajan A, Prabhash K.Switch maintenance Tyrosine kinase inhibitors in EGFR
mutation positive metastatic non squamous NSCLC: Experience from real world. Gulf Journal of Oncology, issue 2 page 6-10, Sept 2016
12. Joshi A, Noronha V, Pandey A, Patil V, Samar A, Mahajan A, Janu A, Prabhash K. Outcomes with palliative weekly paclitaxel in advanced, recurrent, and metastatic esophageal cancer-Real world experience. Indian Journal of Medical and Paediatric Oncology. 2018 Jan 1;39(1):46.
13. Khanna N, Pandey A, Bajpai J. Metastatic ewing's sarcoma: Revisiting the “Evidence on the Fence”. Indian journal of medical and paediatric oncology: official journal of Indian Society of Medical & Paediatric Oncology. 2017 Apr;38(2):173
14. Noronha V, Pandey A, Patil V, Joshi A, Choughule AB, Bhattacharjee A, Kumar R, Goud S, More S, Ramaswamy A, Karpe A. Tyrosine kinase inhibitor versus physician choice chemotherapy in second-line epidermal growth factor receptor mutation non-small cell lung cancer: Post hoc analysis of randomized control trial. Indian Journal of Medical and Paediatric Oncology. 2018 Oct 1;39(4):493.
15. Pandey A, Mishra R, Markandeywar N. Professional outcome of medical graduates: a 17 year cross-sectional study from India. International Journal Of Community Medicine And Public Health. 2017 Sep 22;4(10):3770-6.
16. Madhawi R, Pandey A, Raj S, Mandal M, Devi S, Sinha PK, Singh RK. Geographical pattern of carcinoma gallbladder in Bihar and its association with river Ganges and arsenic levels: Retrospective individual consecutive patient data from Regional Cancer Centre. South Asian journal of cancer. 2018 Jul;7(3):167.

17. Pandey A, Kumar M, Shahi H, Kumari A, Singh S. Novel therapeutic options for recurrent metastatic salivary gland tumors: Review of ongoing clinical trials. Cancer Research, Statistics, and Treatment. 2018 Jan 1;1(1):10.

18. Pandey A. and Singh, A., 2018. Introspection to abandon the'Comfort Zone': Weekly cisplatin no more. Cancer Research, Statistics, and Treatment, 1(2), p.181.

19. Pandey A, Raj S, Madhawi R, Devi S, Singh RK. Cancer trends in Eastern India: Retrospective hospital-based cancer registry data analysis. South Asian Journal of Cancer. 2019 Oct;8(4):215.

20. Pandey A, Singh A, Singh S, Kumar A, Das A, Shahi H, Singh A. Oral smokeless tobacco consumption pattern among rural Indian cancer patients: A prospective survey. South Asian Journal of Cancer. 2020 Jan 1;9(1):17.

21. Pandey A, Singh A, Kumar V, Prakash J, Runu R, Thakur V, Gupta AK, Singh S. Pediatric cancers in Bihar: A retrospective tertiary cancer center study. South Asian Journal of Cancer. 2020 Jan 1;9(1):53.

22. Pandey A, Sengar M, Amre P, Khattry N, Bagal B, Menon H. Outcomes of multiple myeloma in the era of novel agents: A retrospective study from tertiary cancer centre. JIGIMS 2017 Jul 3 (2):27-30

23. Ghadyalpatil NS, Pandey A, Krishnamani I, Srinivas C, Rafiq SJ, Hingmire SS, Maturu N, Reddy R, Kumar KK, Sreekanth K, Gurram BC. First-line management of metastatic non-small cell lung cancer: An Indian perspective. South Asian journal of cancer. 2019 Apr;8(2):73.


24. Biswas G, Pandey A, Ghadyalpatil N, Thomas B, , Ramesh A, Arora Y, Gauda Chandra, Naik V, Joshi A, Ghosh I, Roy Rakesh, Medhi K, Singh T, Dattatreya S, Hingmire S, Parikh PM, Lokeshwar N. Role of Cresp in management of Chemotherapy-Induced Anemia in Cancer Patients – a real world clinical practice audit.(Accepted in PLoS one journal)

25. Dwivedi P, Pandey A, Gujral S, Brijesh A, Shripad B. improved Outcome Of Philadelphia Positive Acute Lymphoblastic Leukemia With Agressive Chemotherapy With Imatinib In Children: A Retrospective Analysis From Tata Memorial Hospital Mumbai: poster# 1058. Pediatric Blood & Cancer. 2014 May 1;61:S22-3.

doordarshan.jpg

NEWS TITLE

26. Pandey A, Singh A, Singh S, Shahi H, Kumar A, Kumari A, Das A. First physician of contact and time to presentation among rural adult cancer patients: A prospective survey. South Asian Journal of Cancer.2019;60:61.
27 Pandey A, Singh A, Singh S, Shahi H, Kumar A, Kumari A, Das A. Smoking Pattern among Rural Indian Cancer Patients: A Prospective Survey. Indian Journal of Medical and Paediatric Oncology. 2020 Apr;41(2).
28. Pande A, Bajpai J. Pulmonary metastasectomy in osteosarcoma: Finite disappointments to keep alive the infinite hope!. Cancer. 2020;57:172-81.
29. Pandey A, Singh A, Singh S, Kumar A. Osimertinib in G719A mutated non-small cell lung cancer with leptomeningeal metastases. Cancer Research, Statistics, and Treatment. 2019 Jan 1;2(1):121.
30.Shakur A,Likhitkar M, Pandey A, Mohan L, Dikshit H. Pharmacovigilance in Oncology: Prospective Observational Study of Adverse Drug Reactions of Anticancer Drugs used in Tertiary Care Hospital of East India. (Accepted for publication).
31. Pandey AV, Singh A. Head-and-neck dermatofibrosarcoma protuberans: Where does imatinib'fit in'?. Cancer Research, Statistics, and Treatment. 2019 Jan 1;2(1):74.
32. Pandey A, Singh A, Singh S, Kumar A, Shahi H, Kumari A. Impact of Chhath festival on health seeking behaviour of local population. International Journal of Community Medicine and Public Health. 2019 Aug;6(8):3284.
33. Pandey A, Singh A, Singh S, Kumar A. Patient- doctor ratio across nine super speciality clinics in government hospital: a cross sectional study. International Journal of Community Medicine and Public Health. 2019 Oct;6(10):4421-4425
34. Pandey A, Dutt S, Singh A, Kumar A, Singh S. Outcomes with liquid biopsy to determine the EGFR mutation status in poor performance status, biopsy-ineligible, advanced NSCLC patients. Cancer Research, Statistics, and Treatment. 2019 Jul 1;2(2):197.
35. Pandey A, Singh A. Treating the older patients with ‘younger’evidence-based therapy: Time to tailor to suit the fragility. Cancer Research, Statistics, and Treatment. 2019 Jul 1;2(2):226.
36. Pandey A, Singh A, Singh S. Prevalence of Vitamin D deficiency in treatment-naive individual consecutive cancer patients. Cancer Research, Statistics, and Treatment. 2020 Jan 1;3(1):25.
37. Pandey AV, Singh A, Singh S. Profile of cancer caregivers among adult Indian rural cancer patients: A prospective survey.J Clin Oncol (2019): e18019-e18019.
38. Pandey A, Noronha V,Joshi A, Prabhash K.Comparison of maintenance strategy in EGFR mutation positive and negative locally advanced metastatic Non squamous cell lung cancer. JIGIMS, Feb 2020, Vol 6-1:26-30
39. Pandey A, Dutt S, Singh A, Kumar A, Singh S. Authors' reply to Chadha et al., Sambath et al., and Sharma et al. Cancer Research, Statistics, and Treatment. 2020 Jan 1;3(1):144.
40. Pandey A, Ghosh J. Upfront maintenance poly (Adenosine Diphosphate Ribose) polymerase inhibitors in ovarian cancer: A ray of hope or just a mirage!. Indian Journal of Medical and Paediatric Oncology. 2020 Apr 1;41(2):173.
41. Pandey A, Deshpande P, Singh A, Singh S, Murari K, Aryan R. Oral Prednisolone, Etoposide, 6-Mercaptopurine (PREM) metronomic chemotherapy in treatment naïve and partially treated acute myeloid leukemia in a resource constrained setting. Cancer Research, Statistics, and Treatment. 2020 Jul 1;3(2):172.
42. Pandey A, Ahlawat S, Singh A, Singh S, Murari K, Aryan R. Outcomes and impact of minimal residual disease (MRD) in pediatric, adolescent and young adults (AYA) with acute lymphoblastic leukemia treated with modified MCP 841 protocol. Cancer Research, Statistics, and Treatment. 2020 Jul 1;3(2):183.
43. Pandey A. Author reply to Shamsi et al. and Vora. Cancer Research, Statistics, and Treatment. 2020 Jul 1;3(2):372.
44. Pandey A, Dutt S, Singh A, Kumar A, Singh S. Authors' reply to Chadha et al., Sambath et al., and Sharma et al. Cancer Research, Statistics, and Treatment. 2020 Jan 1;3(1):144.
45. Pandey A, Singh S, Aryan R, Murari K. Prevalence of Iron, Vitamin B12 deficiency and inflammatory anaemia in treatment naive individual consecutive cancer patients: A cross sectional study. medRxiv. 2020 Jan 1.
46. Khanna N, Pandey A, Bajpai J. Metastatic ewing's sarcoma: Revisiting the “Evidence on the Fence”. Indian Journal of Medical and Paediatric Oncology: Official Journal of Indian Society of Medical & Paediatric Oncology. 2017 Apr;38(2):173.f
47.Pandey A, Noronah V, Joshi A, Prabhash K. Outcome of Maintenance Strategy of EGFR mutation positive and  negative locally advanced and metastatic non squamous Lung Carcinoma. A tertiary cancer Centre Experience. JIGIMS 2020 Jan 1 (2):30-34

Home: Publications
All Videos
Watch Now
Home: Video

CONTACT ME

Near RPS, More, Judge's Colony road,SBI Bank, Saguna More, Danapur Nizamat, Patna, Bihar 801503, India

089699 81217, 07634931217

BMT.jpg
Home: Contact
Home: Blog Feed
Home: Pro Gallery
bottom of page